Article Text

Download PDFPDF
CASE REPORT
Diagnostic value of anti-gp210 antibodies in primary biliary cirrhosis: a case-based review
  1. Florent Valour,
  2. Stéphane Durupt,
  3. Safia Khenifer,
  4. Isabelle Durieu
  1. Department of Médecine Interne, Hospices Civils de Lyon, Pierre Bénite, France
  1. Correspondence to Florent Valour, florent.valour{at}chu-lyon.fr

Summary

Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterised by chronic cholestasis usually associated with antimitochondrial antibodies. Moreover, several types of antinuclear antibodies have been associated with primary biliary cirrhosis. We describe an 83-year-old man, in whom the exploration of a chronic cholestasis led to the diagnosis of primary biliary cirrhosis despite negative antimitochondrial antibodies, regarding the presence of anti-gp210 antibodies. Found in 25% of patients, these antinuclear antibodies must be sought before a strong suspicion of primary biliary cirrhosis with antimitochondrial antibodies negative, as they are highly specific of the disease. They are generally associated with a more aggressive form of PBC.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.